{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31709587", "DateCompleted": {"Year": "2021", "Month": "03", "Day": "24"}, "DateRevised": {"Year": "2021", "Month": "03", "Day": "24"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "11", "Day": "10"}], "Language": ["eng"], "ELocationID": ["10.1111/ced.14129"], "Journal": {"ISSN": "1365-2230", "JournalIssue": {"Volume": "45", "Issue": "4", "PubDate": {"Year": "2020", "Month": "Jun"}}, "Title": "Clinical and experimental dermatology", "ISOAbbreviation": "Clin Exp Dermatol"}, "ArticleTitle": "Acute cutaneous toxicity with kava: an inflammatory sebotropic reaction and urticaria.", "Pagination": {"StartPage": "527", "EndPage": "530", "MedlinePgn": "527-530"}, "AuthorList": [{"Identifier": ["0000-0003-4745-1338"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, St Mary's Hospital, Portsmouth, UK."}], "LastName": "Steele", "ForeName": "L", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, St Mary's Hospital, Portsmouth, UK."}], "LastName": "Cummin", "ForeName": "A", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, St Mary's Hospital, Portsmouth, UK."}], "LastName": "Keohane", "ForeName": "S G", "Initials": "SG"}], "PublicationTypeList": ["Case Reports", "Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Clin Exp Dermatol", "NlmUniqueID": "7606847", "ISSNLinking": "0307-6938"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "9PHQ9Y1OLM", "NameOfSubstance": "Prednisolone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Acute Disease"}, {"QualifierName": [], "DescriptorName": "Aftercare"}, {"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": [], "DescriptorName": "Biopsy"}, {"QualifierName": [], "DescriptorName": "Diagnosis, Differential"}, {"QualifierName": ["chemically induced", "pathology"], "DescriptorName": "Erythema"}, {"QualifierName": ["chemically induced", "pathology"], "DescriptorName": "Exanthema"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Kava"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Prednisolone"}, {"QualifierName": ["chemically induced", "pathology"], "DescriptorName": "Pruritus"}, {"QualifierName": ["chemically induced", "diagnosis", "drug therapy", "pathology"], "DescriptorName": "Skin Diseases"}, {"QualifierName": ["chemically induced", "drug therapy", "pathology"], "DescriptorName": "Systemic Inflammatory Response Syndrome"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}, {"QualifierName": ["chemically induced", "pathology"], "DescriptorName": "Urticaria"}, {"QualifierName": [], "DescriptorName": "Young Adult"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Teschke R, Qiu SX, Lebot V. Herbal hepatotoxicity by kava: update on pipermethystine, flavokavain B, and mould hepatotoxins as primarily assumed culprits. Dig Liver Dis 2011; 43: 676-81."}, {"Citation": "Solomon S. Counting on the trendy to revive kava, a traditional drink. In: New York Times. Available at: https://www.nytimes.com/2017/02/23/business/fiji-kava-prices-drink.html (accessed 28 Feb 2019)"}, {"Citation": "Danan G, Teschke R. RUCAM in drug and herb induced liver injury: the update. Int J Mol Sci 2016; 17: 14"}, {"Citation": "Jappe U, Franke I, Reinhold D, Gollnick HP. Sebotropic drug reaction resulting from kava-kava extract therapy: a new entity? J Am Acad Dermatol 1998; 38: 104-6."}, {"Citation": "Huynh JC, Asgari MM, Moore MM. Sebotropic eruption associated with use of oral kava kava supplement. Clin Exp Dermatol 2014; 39: 816-18."}, {"Citation": "Brown-Joel ZO, Colleran ES, Stone MS. Inflammatory sebotropic reaction associated with kava kava ingestion. JAAD Case Rep 2018; 4: 437-9."}, {"Citation": "Rzepecki AK, Wald J, Amin B et al. Kava-induced acute cutaneous toxicity: an increasingly recognized characteristic clinicohistologic pattern. JAAD Case Rep 2018; 4: 1037-8."}, {"Citation": "Grace R. Kava-induced urticaria. J Am Acad Dermatol 2005; 53: 906."}], "Title": "References"}], "History": [{"Year": "2019", "Month": "9", "Day": "29"}, {"Year": "2019", "Month": "11", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "11", "Day": "12", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["31709587", "10.1111/ced.14129"]}}]}